Ross Gerber, a prominent Tesla investor, has suggested that using Ozempic could lead to significant cost savings. What Happened: Gerber took to X (formerly Twitter) to share his thoughts on the potential financial benefits of using Ozempic, a weight-loss drug developed by Novo Nordisk A/S (NYSE:NVO). Gerber said, “It’s possible that using ozempic might actually save people money too.” He quoted a user who claimed that their expenses at restaurants and grocery stores had drastically decreased since starting the medication, potentially saving them close to $1,000 a month. Gerber’s comment was in…
